We are excited to introduce Dr. Pamela Kunz, a leading advocate for cancer care and gender equity in medicine, as our next oncoinfluencer.
Pamela Kunz is active on X/Twitter and LinkedIn, where she shares her expertise in oncology, healthcare policy, and patient advocacy. As an Associate Professor of Medicine in the Division of Oncology at Yale School of Medicine and Director of the Center for Gastrointestinal Cancers at Yale Cancer Center and Smilow Cancer Hospital, her extensive experience and dedication make her a vital voice in the oncology community.
Follow Pamela Kunz on X/Twitter and LinkedIn to stay informed about her latest work in cancer research and advocacy.
About Pamela Kunz
Dr. Kunz was formerly the director of the Stanford Neuroendocrine Tumor Program and has led significant research initiatives as the Leader of the Endocrine Oncology Research Group and Director of the Neuroendocrine Tumor Fellowship. She is currently the President of the North American Neuroendocrine Tumor Society (NANETS) and Chair of the Neuroendocrine Tumor Taskforce of the National Cancer Institute.
In addition to her clinical and research roles, Dr. Kunz is a strong advocate for promoting gender equity within the medical workforce, currently serving as the Vice Chief for Diversity, Equity, and Inclusion (DEI) for the Section of Medical Oncology at Yale. Her commitment to advancing patient care and healthcare equity positions her as a leading voice in the oncology field.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website featuring influential voices in the oncology community.
